dr. william seeds protocol for bpc-157 tb-500 Richard Silva and Dr. Greg Jones explore the potential of and TPC-157, two peptides that continue to draw attention in the regenerative medicine conversation., As physicians look more View Show Notes From This
Description
2016 Jun 14;23(6):965-966
If there is clinical improvement and if a reticulocyte response is observed, the same amount may be given on alternate days for seven doses, then every three to four days for another two to three weeks
Response time varies based on severity, cause, and duration of neuropathy
Research in mouse tumor models has demonstrated inhibition of cancer cell growth via intraperitoneal administration [4]
